Skip to content

Establishment and validation of NSCLC prognostic model based on 18FDG PET/CT metabolic parameters and clinicopathologic features

Establishment and validation of NSCLC prognostic model based on 18FDG PET/CT metabolic parameters and clinicopathologic features

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400087096
Enrollment
Unknown
Registered
2024-07-19
Start date
2024-07-23
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

Gold Standard:Lung histopathology biopsy

Sponsors

nuclear medicine department,the First Affiliated Hospital of Soochow University,Suzhou City,Jiangsu Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 86 Years

Inclusion criteria

Inclusion criteria: (1) histopathology confirmed NSCLC, (2) complete clinical history, immunohistochemical (IHC) results, and PET/CT images were available, (3) no antitumor therapy prior to histopathological analysis and imaging, and (4) no previous history of malignant tumor other than lung cancer.

Exclusion criteria

Exclusion criteria: (1) pathologic subtypes of NSCLC other than squamous (SCC) and adenocarcinomas (ADC), (2) obvious asymmetry in the shape of the psoas major muscle due to trauma, disease, heredity.

Design outcomes

Primary

MeasureTime frame
PET/CT;total glycolysis;Accuracy ;Specificity ;Sensitivity ;Negative predictive value;

Secondary

MeasureTime frame
Positive predicative value;

Countries

China

Contacts

Public ContactDeng Shengming

the First Affiliated Hospital of Soochow University

dshming@163.com+86 150 5151 0189

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026